======= EDC4 =======
== Gene Information ==
* **Official Symbol**: EDC4
* **Official Name**: enhancer of mRNA decapping 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23644|23644]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q6P2E9|Q6P2E9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=EDC4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EDC4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606030|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: In the process of mRNA degradation, seems to play a role in mRNA decapping. Component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. Promotes complex formation between DCP1A and DCP2. Enhances the catalytic activity of DCP2 (in vitro). {ECO:0000269|PubMed:16364915}.
No Pfam Domain information is available for this gene.
|deadenylation-independent decapping of nuclear-transcribed mRNA|
|nuclear-transcribed mRNA catabolic process, deadenylation-independent decay|
|exonucleolytic catabolism of deadenylated mRNA|
|nuclear-transcribed mRNA catabolic process, exonucleolytic|
|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|
|cytoplasmic ribonucleoprotein granule|
|P-body|
|nuclear-transcribed mRNA catabolic process|
|mRNA catabolic process|
|RNA catabolic process|
|nucleic acid phosphodiester bond hydrolysis|
|nucleobase-containing compound catabolic process|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|aromatic compound catabolic process|
|organic cyclic compound catabolic process|
|mRNA metabolic process|
|cellular macromolecule catabolic process|
|macromolecule catabolic process|
|RNA metabolic process|
|negative regulation of gene expression|
|organic substance catabolic process|
|cellular catabolic process|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp512|Olaparib 4μM R08 exp512]]|-2.24|
|[[:results:exp216|Erlotinib 10μM R05 exp216]]|-1.87|
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.79|
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.71|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|2.48|
|[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|2.89|
^Gene^Correlation^
|[[:human genes:e:edc3|EDC3]]|0.445|
|[[:human genes:d:dcp2|DCP2]]|0.42|
|[[:human genes:c:cnot8|CNOT8]]|0.415|
|[[:human genes:x:xrn1|XRN1]]|0.405|
Global Fraction of Cell Lines Where Essential: 7/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|2/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|1/16|
|kidney|0/21|
|liver|0/20|
|lung|1/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|1/2|
|upper aerodigestive|1/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1655
* **Expression level (log2 read counts)**: 7.02
{{:chemogenomics:nalm6 dist.png?nolink |}}